Associated Papers
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.
Xu D et al.
Embo Molecular Medicine, 2025
40707702 (PubMed )
Supplement: 44321_2025_278_MOESM15_ESM.xlsx › Sheet1
Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L et al.
Molecular Oncology, 2022
35971249 (PubMed )
Supplement: MOL2-16-3689-s005.xlsx › Table_S3
Re-evaluation of missense variant classifications in NF2.
Sadler KV et al.
Human Mutation, 2022
35332608 (PubMed )
Supplement: HUMU-43-643-s001.xlsx › Sheet1
Select a paper to view details